##gff-version 3
##sequence-region Q9UGJ0 1 569
Q9UGJ0	UniProtKB	Chain	1	569	.	.	.	ID=PRO_0000204381;Note=5'-AMP-activated protein kinase subunit gamma-2	
Q9UGJ0	UniProtKB	Domain	275	335	.	.	.	Note=CBS 1;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00703	
Q9UGJ0	UniProtKB	Domain	357	415	.	.	.	Note=CBS 2;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00703	
Q9UGJ0	UniProtKB	Domain	430	492	.	.	.	Note=CBS 3;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00703	
Q9UGJ0	UniProtKB	Domain	504	562	.	.	.	Note=CBS 4;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00703	
Q9UGJ0	UniProtKB	Nucleotide binding	319	322	.	.	.	Note=AMP%2C ADP or ATP 1;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P80385	
Q9UGJ0	UniProtKB	Nucleotide binding	383	384	.	.	.	Note=AMP%2C ADP or ATP 1;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P80385	
Q9UGJ0	UniProtKB	Nucleotide binding	458	459	.	.	.	Note=AMP 3;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P80385	
Q9UGJ0	UniProtKB	Nucleotide binding	474	477	.	.	.	Note=AMP%2C ADP or ATP 2;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P80385	
Q9UGJ0	UniProtKB	Nucleotide binding	530	531	.	.	.	Note=AMP%2C ADP or ATP 2;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P80385	
Q9UGJ0	UniProtKB	Nucleotide binding	546	549	.	.	.	Note=AMP 3;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P80385	
Q9UGJ0	UniProtKB	Motif	370	391	.	.	.	Note=AMPK pseudosubstrate	
Q9UGJ0	UniProtKB	Binding site	302	302	.	.	.	Note=AMP%2C ADP or ATP 2;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P80385	
Q9UGJ0	UniProtKB	Binding site	362	362	.	.	.	Note=AMP%2C ADP or ATP 1%3B via amide nitrogen and carbonyl oxygen;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P80385	
Q9UGJ0	UniProtKB	Binding site	383	383	.	.	.	Note=AMP 3;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P80385	
Q9UGJ0	UniProtKB	Binding site	402	402	.	.	.	Note=AMP%2C ADP or ATP 2;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P80385	
Q9UGJ0	UniProtKB	Binding site	432	432	.	.	.	Note=AMP 3;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P80385	
Q9UGJ0	UniProtKB	Binding site	437	437	.	.	.	Note=AMP 3%3B via amide nitrogen and carbonyl oxygen;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P80385	
Q9UGJ0	UniProtKB	Binding site	501	501	.	.	.	Note=AMP%2C ADP or ATP 2;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P80385	
Q9UGJ0	UniProtKB	Binding site	509	509	.	.	.	Note=AMP%2C ADP or ATP 2%3B via amide nitrogen and carbonyl oxygen;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P80385	
Q9UGJ0	UniProtKB	Binding site	530	530	.	.	.	Note=AMP 3;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P80385	
Q9UGJ0	UniProtKB	Modified residue	65	65	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q91WG5	
Q9UGJ0	UniProtKB	Modified residue	71	71	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24275569;Dbxref=PMID:24275569	
Q9UGJ0	UniProtKB	Modified residue	73	73	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q91WG5	
Q9UGJ0	UniProtKB	Modified residue	90	90	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q91WG5	
Q9UGJ0	UniProtKB	Modified residue	138	138	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q91WG5	
Q9UGJ0	UniProtKB	Modified residue	143	143	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q91WG5	
Q9UGJ0	UniProtKB	Modified residue	161	161	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q91WG5	
Q9UGJ0	UniProtKB	Modified residue	162	162	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q91WG5	
Q9UGJ0	UniProtKB	Modified residue	165	165	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q91WG5	
Q9UGJ0	UniProtKB	Modified residue	196	196	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q91WG5	
Q9UGJ0	UniProtKB	Alternative sequence	1	241	.	.	.	ID=VSP_000261;Note=In isoform B. Missing;Ontology_term=ECO:0000303,ECO:0000303,ECO:0000303,ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:11112354,ECO:0000303|PubMed:14702039,ECO:0000303|PubMed:15489334,ECO:0000303|Ref.1,ECO:0000303|Ref.5;Dbxref=PMID:11112354,PMID:14702039,PMID:15489334	
Q9UGJ0	UniProtKB	Alternative sequence	1	44	.	.	.	ID=VSP_015589;Note=In isoform C. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
Q9UGJ0	UniProtKB	Natural variant	6	6	.	.	.	ID=VAR_048250;Note=M->L;Dbxref=dbSNP:rs3207363	
Q9UGJ0	UniProtKB	Natural variant	302	302	.	.	.	ID=VAR_013264;Note=In WPWS and CMH6%3B impaired AMP- and ATP-binding. R->Q;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11407343,ECO:0000269|PubMed:11827995,ECO:0000269|PubMed:14722619;Dbxref=dbSNP:rs121908987,PMID:11407343,PMID:11827995,PMID:14722619	
Q9UGJ0	UniProtKB	Natural variant	350	350	.	.	.	ID=VAR_013265;Note=In CMH6%3B severe. R->RL;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11371514;Dbxref=PMID:11371514	
Q9UGJ0	UniProtKB	Natural variant	383	383	.	.	.	ID=VAR_013266;Note=In CMH6%3B severe%3B impaired AMP- and ATP-binding. H->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11371514,ECO:0000269|PubMed:14722619;Dbxref=dbSNP:rs121908988,PMID:11371514,PMID:14722619	
Q9UGJ0	UniProtKB	Natural variant	400	400	.	.	.	ID=VAR_013267;Note=In CMH6%3B severe%3B impaired AMP- and ATP-binding. T->N;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11827995,ECO:0000269|PubMed:14722619;Dbxref=dbSNP:rs28938173,PMID:11827995,PMID:14722619	
Q9UGJ0	UniProtKB	Natural variant	488	488	.	.	.	ID=VAR_013268;Note=In CMH6%3B severe. N->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11827995;Dbxref=dbSNP:rs121908989,PMID:11827995	
Q9UGJ0	UniProtKB	Natural variant	531	531	.	.	.	ID=VAR_032909;Note=In WPWS%3B absence of cardiac hypertrophy%3B onset in childhood%3B impaired AMP- and ATP-binding. R->G;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11748095,ECO:0000269|PubMed:14722619;Dbxref=dbSNP:rs121908990,PMID:11748095,PMID:14722619	
Q9UGJ0	UniProtKB	Natural variant	531	531	.	.	.	ID=VAR_013269;Note=In GSDH%3B reduction of binding affinities for AMP and ATP%3B loss of cooperative binding%3B enhanced basal activity%3B increased phosphorylation of the alpha-subunit. R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15877279;Dbxref=dbSNP:rs121908991,PMID:15877279	
Q9UGJ0	UniProtKB	Mutagenesis	387	387	.	.	.	Note=Induces phosphorylation by AMPK. V->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17255938;Dbxref=PMID:17255938	
